# JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Source: https://onco.cc/trials/nct02468024/  
OnCo record `nct02468024` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by University of Texas Southwestern Medical Center, now recruiting.

## Summary

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer is a phase 3, randomised interventional study registered as NCT02468024 by University of Texas Southwestern Medical Center, with a registry enrolment figure of 272 participants, started 2015-07 and due to reach its primary completion in 2028-12. Interventions recorded: Lung Surgery; Radiation therapy. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: overall survival. Lung eligibility wording from the registry: "3 Radiographic findings consistent with non-small cell lung cancer, including lesions with ground glass opacities with a solid component of 50% or greater". Sites: Australia, Canada, United Kingdom, United States. United Kingdom sites listed: 1. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: STABLE-MATES
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT02468024
- Phase: 3
- Setting: JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial
- Sponsor: University of Texas Southwestern Medical Center
- Enrolled: 272

## Notes

- UK sites (registry): The James Cook University Hospital (Middlesbrough).

## Sources

- ClinicalTrials.gov NCT02468024: https://clinicaltrials.gov/study/NCT02468024

## Connected records

- cancers: [Resectable stage I to III non-small-cell lung cancer](https://onco.cc/cancers/resectable-nsclc/)
- technologies: [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct02468024.json